XTL Biopharmaceuticals Ltd.

DB:H2K2 Stock Report

Market Cap: €22.0m

XTL Biopharmaceuticals Ltd. Company Information

XTL Biopharmaceuticals Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: XTL Biopharmaceuticals Ltd.
  • Ticker: H2K2
  • Exchange: DB
  • Founded: 1993
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₪87.804m
  • Listing Market Cap: ₪22.005m
  • Shares Outstanding: 1.25b
  • Website: https://www.xtlbio.com

Number of Employees


Location

  • XTL Biopharmaceuticals Ltd.
  • 26 Ben-Gurion St.
  • Ramat Gan
  • 5112001
  • Israel


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
XTLBTASE (The Tel-Aviv Stock Exchange)YesOrdinary SharesILILSSep 2000
XTLBNasdaqCM (Nasdaq Capital Market)SPON ADS EACH REP 100 ORD SHS(POST SPLT)USUSDSep 2005
H2K2DB (Deutsche Boerse AG)SPON ADS EACH REP 100 ORD SHS(POST SPLT)DEEURSep 2005

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/12 06:57
End of Day Share Price 2024/11/12 00:00
Earnings2024/03/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.